International Stem Cell Corporation Submits Remaining Requested Safety Study Report for Clinical Trial Authorization

CARLSBAD, CA, Jul 30, 2015 (Marketwired via COMTEX) — International Stem Cell Corporation (ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today the submission of the final …

[Read the full article here]

Comments are closed.